Quarterly Report · 10-Q
Emergent Biosolutions, Inc.
EBSNYSEEQUITYCurrent
Quarterly Report
Company context
Joseph Papa President and Chief Executive Officer Richard Lindahl EVP, Chief Financial Officer and Treasurer Jessica Perl SVP, General Counsel and Corporate Secretary Paul Williams SVP, Products Business Coleen Glessner EVP, Quality, Ethics and Compliance Simon Lowry, M.D. Chief Medical Officer, Head of Research and Development Stephanie Duatschek SVP, Chief Strategy and Transformation Officer Michelle Pepin SVP, Chief Human Resources Officer Bill Hartzel SVP, Manufacturing and Bioservices Emergent’s Executive Management Team
Current securities
Recent company filings
- Regulation FD DisclosureSep 14, 2026
- Other EventsSep 1, 2026
- Results of Operations and Financial Condition · Costs Associated with Exit or Disposal Activities · Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements · Regulation FD DisclosureAug 5, 2026
- SCHEDULE 13G/A filingJul 31, 2026
- 144 filingJul 1, 2026
As-filed source
As filedOpen full document ↗